LIXT
NASDAQ · Biotechnology
Lixte Biotechnology Holdings
$7.42
-0.62 (-7.71%)
Open$8.24
Previous Close$8.04
Day High$8.24
Day Low$7.30
52W High$7.78
52W Low$0.68
Volume—
Avg Volume543.8K
Market Cap125.01M
P/E Ratio—
EPS$-1.10
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.59M | 2.67M | 2.41M |
| Net Income | 404.7K | 492.8K | 436.5K |
| Profit Margin | 15.6% | 18.4% | 18.1% |
| EBITDA | 711.7K | 711.0K | 701.7K |
| Free Cash Flow | 315.8K | 252.8K | 287.8K |
| Rev Growth | +13.7% | +15.1% | +4.1% |
| Debt/Equity | 1.15 | 1.36 | 1.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |